naltrexone Vivitrol monthly
Selected indexed studies
- Naltrexone (vivitrol)--a once-monthly injection for alcoholism. (Med Lett Drugs Ther, 2006) [PMID:16874283]
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. (Ann Intern Med, 2018) [PMID:29913516]
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. (Lancet, 2018) [PMID:29150198]
_Worker-drafted node — pending editorial review._
Connections
naltrexone Vivitrol monthly is a side effect of
Sources
- Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. (2025) pubmed
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. (2018) pubmed
- Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients. (2013) pubmed
- Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry. (2018) pubmed
- Extended-release buprenorphine in pregnancy. (2024) pubmed
- Naltrexone (vivitrol)--a once-monthly injection for alcoholism. (2006) pubmed
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. (2018) pubmed
- Long-acting injectable naltrexone for the treatment of alcohol dependence. (2007) pubmed
- Vivitrex (Alkermes/Cephalon). (2006) pubmed
- PMID:22514834 (1998) pubmed